Menu

News

PPD’s Accelerated Enrollment Solutions Acquires Global Site Business from Bioclinica

Accelerated Enrollment Solutions has acquired the clinical research site business of Bioclinica, expanding its global footprint and solidifying AES’ leadership position in patient access and site conduct.

05 Sept. 2019

Harbour BioMed and PPD Form Strategic Collaboration to Develop Innovative Therapeutics for Oncology and Immunology

Harbour BioMed and PPD announced a strategic collaboration to develop HBM’s innovative therapeutics in the fields of oncology and immunology.

27 Aug. 2019

Evidera and CSS Collaborate to Develop Joint Real-world and Patient-centered Research Capabilities in Japan

Evidera, a business unit of PPD, has entered into an exclusive collaboration agreement with CSS, a subsidiary of SNBL, extending both organizations’ capabilities.

21 Aug. 2019

NeoGenomics Announces Grand Opening of new Pharma Services Laboratory in Singapore

NeoGenomics and PPD announced the grand opening of a NeoGenomics oncology-focused clinical trials testing lab in the same building as the PPD Laboratories central lab in Singapore.

31 Jul. 2019

Optimal Just-in-Time Service Changing the Paradigm of Cancer Trials

Optimal Just-in-Time, a service of PPD’s Accelerated Enrollment Solutions (AES) business unit, and Cancer Treatment Centers of America are collaborating to speed patient enrollment in oncology clinical trials.

16 Jul. 2019

U.S. Research Initiative Launches on Brain Aging to Help Prevent, Treat Dementia

The Synexus HealthyMinds Registry has launched and is seeking 30,000 U.S. participants for a five-year study examining the lifestyle and genetic risk factors impacting cognitive function over time.

09 Jul. 2019

Randstad Japan Names PPD-SNBL a Top-Five Growth Business and Desirable Employer

PPD-SNBL has been named a top-five growth business and desirable employer by Randstad Japan.

18 Jun. 2019

Evidera to Acquire Medimix, Expanding Solutions for Real-World Research

Evidera, a business unit of PPD, has entered into an agreement to acquire Medimix International, a global technology company.

30 May 2019

PPD Clinical Research Associates Honored for Excellence in Global Competitions

PPD won multiple honors in the annual PharmaTimes Clinical Researcher of the Year competitions, with 16 PPD clinical research professionals recognized by industry peers for their expertise in the enterprise of drug development.

28 May 2019

PPD Recognized for Excellence in Clinical Research in CRO Leadership Awards

PPD has been recognized for excellence in clinical research for the eighth consecutive year by pharmaceutical and biotech executives surveyed for Life Science Leader magazine’s 2019 CRO Leadership Awards.

01 May 2019

Media Contacts:

Randy Buckwalter Senior Manager, Corporate Communications
PPD
Tel: +1 919 456 4425

Holly Devine Manager, Corporate Communications
PPD
Tel: +1 919 456 6389

Contact Legal Notices Modern Slavery Transparency Statement Privacy Policy

© 2019 Pharmaceutical Product Development, LLC. All rights reserved.